Sol-Gel Technologies Gross Margin 2016-2025 | SLGL

Current and historical gross margin for Sol-Gel Technologies (SLGL) over the last 10 years. The current gross profit margin for Sol-Gel Technologies as of March 31, 2025 is %.
Sol-Gel Technologies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.01B $0.01B 100.00%
2024-12-31 $0.01B $0.01B 100.00%
2024-09-30 $0.01B $0.01B 100.00%
2024-06-30 $0.01B $0.01B 100.00%
2024-03-31 $0.00B $0.00B 100.00%
2023-12-31 $0.00B $0.00B 100.00%
2023-09-30 $0.00B $0.00B 100.00%
2023-06-30 $0.00B $0.00B 100.00%
2023-03-31 $0.00B $0.00B 100.00%
2022-12-31 $0.00B $0.00B 100.00%
2022-09-30 $0.03B $0.03B 100.00%
2022-06-30 $0.03B $0.03B 100.00%
2022-03-31 $0.03B $0.03B 100.00%
2021-12-31 $0.03B $0.03B 100.00%
2021-09-30 $0.01B $0.01B 100.00%
2021-06-30 $0.01B $0.01B 100.00%
2021-03-31 $0.01B $0.01B 100.00%
2020-12-31 $0.01B $0.01B 100.00%
2020-09-30 $0.01B $0.01B 100.00%
2020-06-30 $0.01B $0.01B 100.00%
2020-03-31 $0.02B $0.02B 100.00%
2019-12-31 $0.02B $0.02B 100.00%
2019-09-30 $0.02B $0.02B 100.00%
2019-06-30 $0.01B $0.01B 100.00%
2019-03-31 $0.01B $0.01B 100.00%
2018-12-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.020B $0.012B
Sol-Gel Technologies Ltd.is a clinical-stage dermatology company. It focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. Its product candidates include VERED for the treatment of papulopustular rosacea, TWIN and SIRS-T for the treatment of acne vulgaris, which are in its clinical stage. Sol-Gel Technologies Ltd.is based in Israel.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.716B 7.05
Dr Reddy's Laboratories (RDY) India $12.238B 22.21
BridgeBio Pharma (BBIO) United States $7.124B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.805B 14.65
Bausch Health Cos (BHC) Canada $1.674B 1.22
Amphastar Pharmaceuticals (AMPH) United States $1.226B 8.23
Taysha Gene Therapies (TSHA) United States $0.597B 0.00
Personalis (PSNL) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.116B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00